SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-23-046294
Filing Date
2023-04-17
Accepted
2023-04-17 17:14:27
Documents
8

Document Format Files

Seq Description Document Type Size
1 S-3 tm2312861-1_s3.htm S-3 337543
2 EXHIBIT 5.1 tm2312861d2_ex5-1.htm EX-5.1 11309
3 EXHIBIT 23.1 tm2312861d2_ex23-1.htm EX-23.1 2638
4 EXHIBIT 23.2 tm2312861d2_ex23-2.htm EX-23.2 3008
5 EX-FILING FEES tm2312861d2_exfiling-fees.htm EX-FILING FEES 25191
6 GRAPHIC tm2312861d2_ex5-img002.gif GRAPHIC 2247
7 GRAPHIC tm2312861d2_ex5-img001.jpg GRAPHIC 6430
8 GRAPHIC lg_carismatherapeutics-4c.jpg GRAPHIC 101495
  Complete submission text file 0001104659-23-046294.txt   533082
Mailing Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104 2674916422
Carisma Therapeutics Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | State of Incorp.: PA | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-271296 | Film No.: 23824723
SIC: 2834 Pharmaceutical Preparations